Related Experiment Video
Updated: Jul 27, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Rapid, sensitive and efficient HPLC assays for HIV-1 proteinase
R Betageri1, J L Hopkins, D Thibeault
1Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT 06877-0368.
New assays measure human immunodeficiency virus type 1 (HIV-1) proteinase activity. These methods use high-performance liquid chromatography (HPLC) for sensitive detection of enzyme activity, enabling new research into HIV-1 drug development.
Area of Science:
- Biochemistry
- Virology
- Analytical Chemistry
Background:
- Human immunodeficiency virus type 1 (HIV-1) proteinase is essential for viral maturation.
- Accurate measurement of HIV-1 proteinase activity is crucial for developing antiviral therapies.
Purpose of the Study:
- To develop sensitive and efficient assays for measuring HIV-1 proteinase activity.
- To establish methods for quantifying enzyme kinetics and substrate cleavage.
Main Methods:
- Development of two high-performance liquid chromatography (HPLC)-based assays.
- Assay 1: Utilizes UV detection for separation of unlabeled substrate and products.
- Assay 2: Employs a fluorescein-labeled peptide substrate with fluorescence detection for enhanced sensitivity and speed.
Main Results:
- Achieved detection of enzyme concentrations as low as 1 nM with the unlabeled assay.
- The fluorescein-labeled assay provides rapid analysis (<3 min) with minimal interference.
- Demonstrated the synthesis of fluorescein-labeled peptide substrates via solid-phase peptide synthesis.
Conclusions:
- The developed HPLC assays offer sensitive and versatile tools for HIV-1 proteinase activity measurement.
- The fluorescein-labeled assay represents a significant advancement in speed and sensitivity for enzyme activity studies.
- These assays can facilitate the discovery and evaluation of novel HIV-1 inhibitors.
More Related Videos
08:33Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
19:23Use of Recombinant Fusion Proteins in a Fluorescent Protease Assay Platform and Their In-gel Renaturation
Published on: January 16, 2019